Differential Regulation of Protein-tyrosine Phosphatases by Integrin 


through Cytoskeletal Reorganization and Tyrosine Phosphorylation in Human Platelets (*)
- From the (1) First Division, Department of Internal Medicine, Faculty of Medicine, Kyoto University, 54 Shogoin-Kawaramachi, Sakyo-ku, Kyoto 606, Japan
- §To whom correspondence should be addressed. Tel.: 81-75-751-3151; Fax: 81-75-751-3201.
Abstract
The major platelet integrin α
β3 (glycoprotein IIb-IIIa) has been implicated in the regulation of tyrosine phosphorylation and dephosphorylation in activated
platelets. To investigate the mechanisms of the α
β3-dependent tyrosine dephosphorylation, normal platelets or thrombasthenic platelets lacking α
β3 were stimulated with thrombin and fractionated into Triton X-100-soluble or -insoluble subcellular matrices. We then examined
the kinetics of the tyrosine-phosphorylated proteins and distribution of protein-tyrosine phosphatases in these fractions
and whole cell lysates. First, α
β3-dependent tyrosine dephosphorylation was recovered mainly in the cytoskeleton with similar kinetics to the whole cell lysate.
Second, protein-tyrosine phosphatase (PTP) 1B and its cleaved 42-kDa form were associated with the cytoskeleton in an aggregation-dependent
manner, whereas association of PTP1C with the cytoskeleton was regulated differentially both by thrombin stimulation and by
α
β3-mediated aggregation. Several calpain inhibitors did not affect either tyrosine phosphorylation and dephosphorylation or
relocation of PTP1B, but they did inhibit cleavage of PTP1B. Cytochalasin D blocked relocation of both PTP1B and PTP1C but
not PTP1B cleavage. SH-PTP2 was distributed in the other fractions than the cytoskeleton and showed no relocation on thrombin
stimulation. Finally, the cytoskeleton-associated PTP1C became tyrosine-phosphorylated in an α
β3-mediated aggregation-dependent manner. Thus, integrin α
β3 was involved differentially in the regulation of PTP1B and PTP1C.
Footnotes
-
↵* This work was supported by a grant-in-aid for general scientific research from the Ministry of Education, Science and Culture, Japan. This study was presented at the 1994 Annual Meeting of the American Society of Hematology, Nashville, TN and published in abstract form (Ezumi, Y., Takayama, H., Ichinohe, T., Hirai, K., Tomo, K., and Okuma, M. (1994) Blood 84, 321a). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵1 The abbreviations used are:
- PTK
-
protein-tyrosine kinase
- PTPase
-
protein-tyrosine phosphatase
- SH2
-
Src homology 2
- RGDS
-
Arg-Gly-Asp-Ser
- IgG
-
immunoglobulin G
- PMSF
-
phenylmethylsulfonyl fluoride
- RIPA
-
radioimmunoprecipitation assay
- PAGE
-
polyacrylamide gel electrophoresis
- EST
-
ethyl (+)-(2S, 3S)-3-[(S)-methyl-1-(3-methylbutylcarbamoyl)]-2-oxiranecarboxylate
- MDL
-
carbamic acid, [1-[[(1-formyl-2-phenylmethyl)amino]carbonyl]-2-methylpropyl]-, phenylmethyl ester.
-
↵2Y. Ezumi, H. Takayama, and M. Okuma, unpublished observations.
- © 1995 by The American Society for Biochemistry and Molecular Biology, Inc.











